(Enrichment Program) The Enrichment Program of the Indiana Diabetes Research Center (IDRC) will foster interaction and scientific discussion among faculty, students and postdoctoral fellows at Indiana University School of Medicine and Purdue University, enhance interest in diabetes and diabetes-related research within both institutions, and catalyze the dissemination of the latest research advances and techniques within the diabetes field, to the IDRC community to facilitate their research tasks. The Enrichment Program will achieve these goals by pursuing the following Specific Aims: (1) Coordinate and/or provide activities that promote exchange of ideas and scientific discussion; (2) Enhance interdisciplinary interactions; (3) Promote interactions among IDRC researchers; (4) Foster training of students and fellows. These goals will be accomplished through a variety of seminar series, scientific symposiums, graduate courses, and training programs. The yearly highlight will be an Annual Diabetes Symposium, where the latest and most innovative research in the IDRC will be presented. The Enrichment Program will interact continually with the Executive Committee to review its activities and enhance its program. Overall, the Enrichment Program plays a vital role in disseminating data among IDRC members, exchanging new ideas, promoting scientific discussion and collaboration, and keeping investigators at the forefront of diabetes research.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Center Core Grants (P30)
Project #
5P30DK097512-04
Application #
9509443
Study Section
Special Emphasis Panel (ZDK1)
Project Start
Project End
Budget Start
2018-06-01
Budget End
2019-05-31
Support Year
4
Fiscal Year
2018
Total Cost
Indirect Cost
Name
Indiana University-Purdue University at Indianapolis
Department
Type
DUNS #
603007902
City
Indianapolis
State
IN
Country
United States
Zip Code
46202
Thompson, Kayla; Chen, Jonathan; Luo, Qianyi et al. (2018) Advanced glycation end (AGE) product modification of laminin downregulates Kir4.1 in retinal Müller cells. PLoS One 13:e0193280
Lakhter, Alexander J; Pratt, Rachel E; Moore, Rachel E et al. (2018) Beta cell extracellular vesicle miR-21-5p cargo is increased in response to inflammatory cytokines and serves as a biomarker of type 1 diabetes. Diabetologia 61:1124-1134
Li, Wei; Risacher, Shannon L; Gao, Sujuan et al. (2018) Type 2 diabetes mellitus and cerebrospinal fluid Alzheimer's disease biomarker amyloid ?1-42 in Alzheimer's Disease Neuroimaging Initiative participants. Alzheimers Dement (Amst) 10:94-98
Kono, Tatsuyoshi; Tong, Xin; Taleb, Solaema et al. (2018) Impaired Store-Operated Calcium Entry and STIM1 Loss Lead to Reduced Insulin Secretion and Increased Endoplasmic Reticulum Stress in the Diabetic ?-Cell. Diabetes 67:2293-2304
de Groot, Mary; Marrero, David; Mele, Lisa et al. (2018) Depressive Symptoms, Antidepressant Medication Use, and Inflammatory Markers in the Diabetes Prevention Program. Psychosom Med 80:167-173
RISE Consortium (2018) Metabolic Contrasts Between Youth and Adults With Impaired Glucose Tolerance or Recently Diagnosed Type 2 Diabetes: I. Observations Using the Hyperglycemic Clamp. Diabetes Care 41:1696-1706
Stephens, Clarissa Hernandez; Orr, Kara S; Acton, Anthony J et al. (2018) In situ type I oligomeric collagen macroencapsulation promotes islet longevity and function in vitro and in vivo. Am J Physiol Endocrinol Metab 315:E650-E661
Layton, Jill; Li, Xiaochen; Shen, Changyu et al. (2018) Type 2 Diabetes Genetic Risk Scores Are Associated With Increased Type 2 Diabetes Risk Among African Americans by Cardiometabolic Status. Clin Med Insights Endocrinol Diabetes 11:1179551417748942
Xiang, Anny H; Trigo, Enrique; Martinez, Mayra et al. (2018) Impact of Gastric Banding Versus Metformin on ?-Cell Function in Adults With Impaired Glucose Tolerance or Mild Type 2 Diabetes. Diabetes Care 41:2544-2551
Mastracci, Teresa L; Turatsinze, Jean-Valery; Book, Benita K et al. (2018) Distinct gene expression pathways in islets from individuals with short- and long-duration type 1 diabetes. Diabetes Obes Metab 20:1859-1867

Showing the most recent 10 out of 117 publications